Blog Carnival: Cell and gene therapy industry to emerge stronger post-COVID-19

by Stacey Johnson | Aug 26, 2020

Finally, COVID-19 is no longer the only topic dominating the news cycle, although it took several months before mainstream media felt they could move away from covering a global pandemic that was likely affecting every person on the planet. In some ways it was a...

Regenerative medicine and COVID-19: The search for a silver lining

by David Kent | Aug 26, 2020

As the nations of the world very slowly emerge out of the various states of lockdown and adjust to the new normal of social distancing, working from home, and staggering shifts, it gives us an opportunity to reflect on the past six months of world-changing events...

What COVID-19 has taught me about the future of personalized therapies

by Guest | Aug 26, 2020

Brent McPherson has spent over 25 years in the supply chain sector, managing clients and teams in both local and regional roles (APAC), covering many industries and sectors. Over the past 10 years, his main focus has been on the healthcare sector. From a...

“It was the best of times, it was the worst of times….”

by Michael May | Aug 26, 2020

It is difficult to imagine how many times the opening lines to Charles Dickens’ classic A Tale of Two Cities, written over 160 years ago, has been used to describe the world’s current state of affairs. Yet, I am challenged to identify any other time during my...

What stroke patients can teach us about treating COVID-19

by Tara Fernandez | Aug 26, 2020

Regenerative medicines could have life-saving potential by dampening inflammation The COVID-19 pandemic is one of modern medicine’s greatest challenges. There have been 20 million (and counting) confirmed cases worldwide and, if predictions are right, the worst is yet...

Can COVID-19 be a shot in the arm for cell and gene therapy?

by Guest | Aug 26, 2020

Phil Vanek is responsible for technical due diligence and evaluation of potential investments, as well as guiding operational, R&D and strategic initiatives carried out at portfolio companies. An entrepreneurial and strategic international business leader, Phil...

Covid-19 infects lab-grown mini-organs: Here’s how the new organoid technology is contributing to COVID-19 research

by Guest | Aug 20, 2020

Elisa D’Arcangelo holds a PhD in Biomedical Engineering from the University of Toronto. She is working as a Postdoctoral Fellow at the Princess Margaret Cancer Centre, using tissue engineering and organoid approaches to understand the lung cancer microenvironment and...

Exploring science education through art

by Eleni Kanavas | Aug 13, 2020

Science and art are two worlds that, when blended together, ignite creative collaborations among scientists, educators and artists. Understanding how the arts contribute to science and education has been a topic of interest for academic scholars raising awareness...

Right Turn: Regenerative medicine-related entertainment/edutainment

by Stacey Johnson | Aug 7, 2020

These days it can be very tempting to turn off the news, shut down the negativity on social media and find one’s happy place. Some of you escape into the world of cute pet videos or following animal accounts on Instagram (may I recommend my own furry friend...

Right Turn: Get ready for your favourite summer carnival!

by Stacey Johnson | Jul 31, 2020

Since 1967, the Caribbean community in Toronto, Canada, has been the focus of North America’s largest carnival, commonly referred to as Caribana by locals. This is Caribana weekend. It’s a popular event for Torontonians and people from around the world who descend on...